C4 Therapeutics (CCCC) Q1 2025 Earnings

Feb 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.49
-0.42
-0.34
-0.26

Details

Expected EPS
-0.493054
Actual EPS
-0.49
Surprise EPS
0
Surprise Percent
+0.62%

Description

⁨C4 Therapeutics⁩ (⁦CCCC⁩) has reported earnings of ⁦-0.49⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts